Delivery Order SPE2DR25D6028-SPE2DR26FARKV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $1,701.54. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $7,070.12. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $1,141.79. This non-set-aside award represents a competitive delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The ultimate completion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,939.11 to AmerisourceBergen Drug Corp for the supply of Cefdinir 300 mg capsules (60-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Cefdinir is a third-generation cephalosporin antibiotic commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) valued at $8,449.72. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefdinir 300 mg capsules (60-count) at a ceiling value of $1,347.10. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Cefdinir 300mg capsules (60-count units) under a firm fixed-price contract valued at $6,707.88. This non-set-aside award, with an ultimate completion date of September 30, 2025, represents a routine pharmaceutical procurement to support federal medical requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cefdinir 300 mg capsules (60-count units) under a firm fixed-price contract valued at $1,064.64. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive delivery order executed without a set-aside designation. Performance will be completed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp has been awarded a competitive delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain for the supply of Cefdinir 300 mg capsules (60-count units) valued at $4,258.56. The award was issued on September 24, 2025, with an ultimate completion date of the same day, indicating this represents a time-sensitive delivery order under a larger contract vehicle. The delivery is to be performed at the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cefdinir 300 mg capsules (60-count units) with a ceiling value of $1,839.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents no set-aside designation and is issued as a child order under a larger contract...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARKVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Cefdinir 300mg capsules (60-count units) with a ceiling value of $13,352.55. This firm fixed-price delivery order, which represents a competitive award with no set-aside designation, is scheduled for completion by December 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, continues to serve the Defense Health Agency and other government healthcare systems through this flexible contract vehicle. The company's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains—ranging from antibiotics such as this cefdinir order to specialty medications and medical supplies—demonstrates its established capability to meet federal pharmaceutical procurement requirements efficiently and reliably at various order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 11/7/25 |